Pfizer
PFE
PFE
2,201 hedge funds and large institutions have $152B invested in Pfizer in 2018 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 820 increasing their positions, 1,047 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
1% less funds holding
Funds holding: 2,226 → 2,201 (-25)
2% less funds holding in top 10
Funds holding in top 10: 180 → 176 (-4)
22% less repeat investments, than reductions
Existing positions increased: 820 | Existing positions reduced: 1,047
Holders
2,201
Holding in Top 10
176
Calls
$911M
Puts
$961M
Top Buyers
| 1 | +$753M | |
| 2 | +$346M | |
| 3 | +$284M | |
| 4 |
JP Morgan Chase
New York
|
+$259M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$254M |
Top Sellers
| 1 | -$335M | |
| 2 | -$320M | |
| 3 | -$262M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$212M |
| 5 |
State Street
Boston,
Massachusetts
|
-$206M |